Advertisement
UK markets close in 1 hour 40 minutes
  • FTSE 100

    8,054.18
    +13.80 (+0.17%)
     
  • FTSE 250

    19,578.45
    -140.92 (-0.71%)
     
  • AIM

    752.92
    -1.77 (-0.23%)
     
  • GBP/EUR

    1.1656
    +0.0012 (+0.10%)
     
  • GBP/USD

    1.2469
    +0.0006 (+0.05%)
     
  • Bitcoin GBP

    50,760.25
    -2,249.60 (-4.24%)
     
  • CMC Crypto 200

    1,364.08
    -18.49 (-1.34%)
     
  • S&P 500

    5,002.72
    -68.91 (-1.36%)
     
  • DOW

    37,884.49
    -576.43 (-1.50%)
     
  • CRUDE OIL

    82.63
    -0.18 (-0.22%)
     
  • GOLD FUTURES

    2,332.40
    -6.00 (-0.26%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,844.45
    -244.25 (-1.35%)
     
  • CAC 40

    7,969.56
    -122.30 (-1.51%)
     

How Spark's Gene Therapy Win Could Also Be A Boon For These Biotechs

How Spark's Gene Therapy Win Could Also Be A Boon For These Biotechs

Spark's positive vote by an FDA committee could be a boon for other drugmakers working on gene therapies including Audentes, BioMarin and Ultragenyx.